AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ProdiGene, NIH begin study on oral vaccine derived from transgenic corn.(Brief Article)
2002 SEP 18 - (NewsRx.com & NewsRx.net) -- ProdiGene, Inc., announced that it will begin a phase I clinical trial in cooperation with the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID), studying the safety and immunogenicity of an oral vaccine against Traveler's Diarrhea, a condition caused by Enterotoxigenic E. coli (ETEC).
This vaccine is produced using ProdiGene's proprietary transgenic plant technology and delivered using the company's patented oral vaccine platform.
Under the agreement, NIAID will fund the trial and ProdiGene will supply the corn vaccine. In addition to funding the trial, NIAID will manage the trial and sponsor the submission of an Investigational new drug application with the U.S. Food and Drug Administration.
"ProdiGene is very pleased that the NIAID has chosen to collaborate with us in this phase I trial designed to test the company's patented oral vaccine technology in combination with the company's ...
- ProdiGene and NIH Beginning Phase I Study on Oral Vaccine Derived from...
- Press release article from: PR Newswire August 12, 2002 700+ words
...Company's patented oral vaccine platform. Under...fund the trial and ProdiGene will supply the...first time that ProdiGene will use its oral vaccine technology in humans...developing countries. ProdiGene's oral vaccine patent was voted...
- ProdiGene Receives Broad Patent for Oral Vaccines; - Plant Process Develops...
- Press release article from: PR Newswire October 24, 2000 700+ words
...collaboratively to ensure many oral vaccine products reach the...marketplace." Previously, ProdiGene received patents for...acquire the TGEV patent, ProdiGene was able to demonstrate the ability of its oral vaccine to overcome a major...an immune response. ProdiGene's vaccine ...
- ProdiGene Announces Appointment of Russell Burbank as CEO.
- Press release article from: PR Newswire March 5, 2003 700+ words
...extensive business experience to ProdiGene. During his career, which...Dr. Howard is a founder of ProdiGene and has been a Director of...by the company's patented oral vaccine platform. Dr. Howard has...California at Riverside. About ProdiGene ProdiGene, headquartered...
- ProdiGene is First to Demonstrate Vaccination With Edible Vaccines.
- Press release article from: PR Newswire February 15, 2000 700+ words
...Clinical trials conducted by ProdiGene, a biopharmaceutical company...for the first time that an oral vaccine expressed in plants gives...said Joe Jilka, Ph.D., ProdiGene vice president of product...vaccines," said Dan Hammes, ProdiGene vice president of operations...
- Sigma-Aldrich Fine Chemicals signs trypsin manufacturing deal with ProdiGene....
- Magazine article from: Chemical Week Wood, Andrew October 16, 2002 700+ words
...development experience with ProdiGene, this is a very scalable...business development at ProdiGene. As well as its use in insulin...year, to $240 million. Prodigene says it is also developing...antibodies, and enzymes. Its oral vaccine for traveler's diarrhea...
- ProdiGene Announces a Research Agreement With FibroGen To Produce Gelatin in...
- Press release article from: PR Newswire June 5, 2002 700+ words
COLLEGE STATION, Texas -- ProdiGene, Inc. announced today that it has...collaboration will focus on the use of ProdiGene's proprietary transgenic plant...and human-derived proteins make ProdiGene's expertise in the area of recombinant...
- ProdiGene Announces Milestone in NIH Collaboration for AIDS Vaccine; -...
- Press release article from: PR Newswire April 9, 2002 700+ words
KEYSTONE, Colo. -- ProdiGene, Inc., a leader in the development...delivery system for an AIDS vaccine. ProdiGene has successfully expressed SIV gp120...in AIDS research. Additionally, ProdiGene scientists will begin animal studies...
- ProdiGene Begins Scale-Up of Aprotinin from Plants; - Provides Non-Animal...
- Press release article from: PR Newswire July 16, 2002 700+ words
COLLEGE STATION, Texas -- ProdiGene, Inc., a leader in the development...undergoing cardiac bypass surgery. ProdiGene holds the patent for exclusive commercial...alternative to animal-derived material. ProdiGene's recombinant aprotinin is equivalent...
- ProdiGene Completes Merger and Private Financing
- Press release article from: PR Newswire February 4, 1997 700+ words
...STATION, Texas, Feb. 4 /PRNewswire/ -- ProdiGene, Inc., formerly Terramed, Inc., announced...investors, according to John Howard, ProdiGene's president and chief executive officer. ProdiGene is commercializing the world's first...
- ProdiGene agrees to buy soybeans in crop incident.(soybeans may have been...
- Magazine article from: Feedstuffs Schuff, Sally November 25, 2002 700+ words
WASHINGTON, D.C. -- ProdiGene, a biotechnology company pioneering...corn on ground used last year for a ProdiGene field test. The Food & Drug...19 as part of an agreement with ProdiGene that will strengthen the company...
Source: HighBeam Research, ProdiGene, NIH begin study on oral vaccine derived from transgenic...